Childhood malignant non-Hodgkin lymphomas of uncommon histology
- PMID: 1640726
Childhood malignant non-Hodgkin lymphomas of uncommon histology
Abstract
Uncommon histologies were identified in 36 of 1336 cases (2.7%) of newly diagnosed childhood non-Hodgkin lymphoma (NHL). Seventeen cases were classified as follicular (six cases as mixed small and large cell, nine as large cell, and two as small non-cleaved cell) and 19 cases as diffuse (18 cases as mixed small and large cell, and one as small cell lymphocytic). The follicular pattern group included a preponderance of male patients; the median age at diagnosis was 11.7 years. These children presented primarily with low-stage disease involving lymph nodes or tonsils. All patients except one achieved complete remission and remain disease-free for 11 months to 18.8 years (actuarial 5-year event-free survival, 94%). The group with diffuse histologies was similar in sex ratio, age at diagnosis (median = 12.1 years), and nodal involvement, but tended to have more advanced-stage disease. Moreover, only 14 of 19 (74%) children with diffuse intermediate-grade histologies are alive in continuous complete remission (actuarial 5-year event-free survival, 70%). These results suggest that follicular pattern childhood NHL has an excellent prognosis, whereas cases with diffuse intermediate-grade histology are prognostically similar to those with diffuse high-grade histologies.
Similar articles
-
Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.Klin Padiatr. 1990 Jul-Aug;202(4):258-61. doi: 10.1055/s-2007-1025530. Klin Padiatr. 1990. PMID: 2203939 Clinical Trial.
-
Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.J Pediatr Hematol Oncol. 2004 Sep;26(9):555-60. J Pediatr Hematol Oncol. 2004. PMID: 15342981
-
Treatment results of tonsillar lymphoma: a 10-year experience.Ann Hematol. 2005 Apr;84(4):223-6. doi: 10.1007/s00277-004-0860-0. Epub 2004 Mar 23. Ann Hematol. 2005. PMID: 15042316
-
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111. J Clin Oncol. 2003. PMID: 12775737 Review.
-
Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas.Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S141-6. doi: 10.1016/j.clml.2015.02.006. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26297267 Review.
Cited by
-
[Clinical observation of five pediatric-type follicular lymphoma in adult].Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):393-397. doi: 10.3760/cma.j.issn.0253-2727.2019.05.009. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31207704 Free PMC article. Chinese.
-
A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.Mod Pathol. 2016 Oct;29(10):1212-20. doi: 10.1038/modpathol.2016.102. Epub 2016 Jun 24. Mod Pathol. 2016. PMID: 27338637 Free PMC article.
-
Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials.Haematologica. 2010 Feb;95(2):253-9. doi: 10.3324/haematol.2009.013177. Epub 2009 Aug 13. Haematologica. 2010. PMID: 19679882 Free PMC article.